Impactful Mutations in Mpro of the SARS-CoV-2 Proteome

被引:0
|
作者
Wolfe, Gideon [1 ]
Belhoussine, Othmane [1 ]
Dawson, Anais [1 ]
Lisaius, Maxwell [1 ]
Jagodzinski, Filip [1 ]
机构
[1] Western Washington Univ, Bellingham, WA 98225 USA
关键词
SARS-CoV-2; mutations; computational biology;
D O I
10.1145/3388440.3414706
中图分类号
TP39 [计算机的应用];
学科分类号
081203 ; 0835 ;
摘要
We explore how amino acid mutations affect the stability of the 306 residue main protease of the COVID-19 proteome. We employ two computational approaches, Site Directed Mutagenesis (SDM) and short runs of Molecular Dynamics. We focus our attention on residues 25-32 that make up a beta sheet of a canonical beta barrel close to an active site which includes Histidine 41. We considered this region a good candidate for mutations because such a large perturbation of a highly structured region close to the active site may prove to be highly detrimental to the protein's stability and may affect catalytic efficiency. Understanding how amino acid mutations affect the stability of the protein can inform efforts to develop pharmacological interventions. We mutated the 8 residues in silico to all other possible amino acids, and analyzed the resulting 152 mutants. Both computational methods predict that only a few specific mutations to some of the 8 residues have a major effect on the structural stability of the protein.
引用
收藏
页数:3
相关论文
共 50 条
  • [1] Contributions of Hyperactive Mutations in Mpro from SARS-CoV-2 to Drug Resistance
    Flynn, Julia M.
    Zvornicanin, Sarah N.
    Tsepal, Tenzin
    Shaqra, Ala M.
    Yilmaz, Nese Kurt
    Jia, Weiping
    Moquin, Stephanie
    Dovala, Dustin
    Schiffer, Celia A.
    Bolon, Daniel N. A.
    ACS INFECTIOUS DISEASES, 2024, 10 (04): : 1174 - 1184
  • [2] Impact of Early Pandemic Stage Mutations on Molecular Dynamics of SARS-CoV-2 Mpro
    Amamuddy, Olivier Sheik
    Verkhivker, Gennady M.
    Bishop, Ozlem Tastan
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2020, 60 (10) : 5080 - 5102
  • [3] Advances in the Development of SARS-CoV-2 Mpro Inhibitors
    Agost-Beltran, Laura
    de la Hoz-Rodriguez, Sergio
    Bou-Iserte, Lledo
    Rodriguez, Santiago
    Fernandez-de-la-Pradilla, Adrian
    Gonzalez, Florenci V.
    MOLECULES, 2022, 27 (08):
  • [4] The zinc proteome of SARS-CoV-2
    Andreini, Claudia
    Arnesano, Fabio
    Rosato, Antonio
    METALLOMICS, 2022, 14 (07)
  • [5] Discovery of PLpro and Mpro Inhibitors for SARS-CoV-2
    Puhl, Ana C.
    Godoy, Andre S.
    Noske, Gabriela D.
    Nakamura, Aline M.
    Gawriljuk, Victor O.
    Fernandes, Rafaela S.
    Oliva, Glaucius
    Ekins, Sean
    ACS OMEGA, 2023, 8 (25): : 22603 - 22612
  • [6] High-Resolution Substrate Specificity Profiling of SARS-CoV-2 Mpro; Comparison to SARS-CoV Mpro
    Yaghi, Rasha M.
    Andrews, Collin L.
    Wylie, Dennis C.
    Iverson, Brent L.
    ACS CHEMICAL BIOLOGY, 2024, 19 (07) : 1474 - 1483
  • [7] Resistance to nirmatrelvir due to mutations in the Mpro in the subvariants of SARS-CoV-2 Omicron: Another concern?
    Chatterjee, Srijan
    Bhattacharya, Manojit
    Dhama, Kuldeep
    Lee, Sang-Soo
    Chakraborty, Chiranjib
    MOLECULAR THERAPY-NUCLEIC ACIDS, 2023, 32 : 263 - 266
  • [8] SARS-CoV-2 Mpro inhibitors: identification of anti-SARS-CoV-2 Mpro compounds from FDA approved drugs
    Bharadwaj, Shiv
    Azhar, Esam Ibraheem
    Kamal, Mohammad Amjad
    Bajrai, Leena Hussein
    Dubey, Amit
    Jha, Kanupriya
    Yadava, Umesh
    Kang, Sang Gu
    Dwivedi, Vivek Dhar
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2022, 40 (06): : 2769 - 2784
  • [9] SARS-CoV-2 Mpro oligomerization as a potential target for therapy
    Lis, Kinga
    Plewka, Jacek
    Menezes, Filipe
    Bielecka, Ewa
    Chykunova, Yuliya
    Pustelny, Katarzyna
    Niebling, Stephan
    Garcia, Angelica Struve
    Garcia-Alai, Maria
    Popowicz, Grzegorz M.
    Czarna, Anna
    Kantyka, Tomasz
    Pyrc, Krzysztof
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2024, 267
  • [10] An Investigation of Nirmatrelvir (Paxlovid) Resistance in SARS-CoV-2 Mpro
    Yaghi, Rasha M.
    Wylie, Dennis C.
    Andrews, Collin L.
    Dickert, Olivia H.
    Ram, Anjana
    Iverson, Brent L.
    ACS BIO & MED CHEM AU, 2024, 4 (06): : 280 - 290